Stock Runners: Arena Pharmaceuticals (NASDAQ:ARNA), AT&T, Inc. (NYSE:T), Rosetta Genomics (NASDAQ:ROSG), The Buckle, Inc. (NYSE:BKE), ReneSola Ltd. (NYSE:SOL)

On 1 AUG Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued its quarterly earnings data on Friday. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.11) by $0.14. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) belongs to Healthcare sector. Its weekly performance is -0.48%. On last trading day company shares ended up $4.18. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is -17.15%.

On 22 AUG AT&T, Inc. (NYSE:T) said that it plans to bring its ultra-fast internet speeds to Silicon Valley, the home of tech giants Apple Inc. and Google Inc making it the first region in California to receive the service. AT&T, Inc. (NYSE:T) shares moved up 0.03% in last trading session and ended the day at $34.51. T Gross Margin is 59.20% and its return on assets is 6.30%. AT&T, Inc. (NYSE:T) quarterly performance is -0.72%.

On 29 JULY Rosetta Genomics, Ltd. (NASDAQ:ROSG) announced that the Company has entered into a collaborative research and license agreement with Yeda Research and Development Co. Ltd., the commercial arm of the Weizmann Institute of Science. The agreement involves collaboration with the Nancy and Stephen Grand Israel National Center for Personalized Medicine to develop novel methods for the preparation of next-generation sequencing libraries for small RNAs. The initial goals of this collaboration are to make this type of sequencing more cost effective as well as to minimize sequence-specific biases. On 25 August, Rosetta Genomics, Ltd. (NASDAQ:ROSG) shares fell -0.27% and was closed at $3.71. ROSG EPS growth in last 5 year was 49.80%. Rosetta Genomics, Ltd. (NASDAQ:ROSG) year to date (YTD) performance is 27.05%.

On 21 AUG The Buckle, Inc. (NYSE:BKE) issued its quarterly earnings data on Thursday. The company reported $0.51 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.53 by $0.02. The company had revenue of $235.70 million for the quarter, compared to the consensus estimate of $253.13 million. During the same quarter last year, the company posted $0.52 earnings per share. The Buckle’s revenue was up 1.4% compared to the same quarter last year. The Buckle, Inc. (NYSE:BKE) ended the last trading day at $48.88. Company weekly volatility is calculated as 2.87%and price to cash ratio as 12.33. The Buckle, Inc. (NYSE:BKE) showed a weekly performance of 5.80%.

On 12 AUG ReneSola Ltd. (NYSE:SOL) reported Q2 EPS of $0.01, $0.11 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $387.1 million versus the consensus estimate of $401.43 million. ReneSola Ltd. (NYSE:SOL) shares fell -1.48% in last trading session and ended the day on $2.67. SOL Gross Margin is 9.30% and its return on assets is -10.90%. ReneSola Ltd. (NYSE:SOL) quarterly performance is -2.91%.